JP2024528540A5 - - Google Patents

Info

Publication number
JP2024528540A5
JP2024528540A5 JP2023580744A JP2023580744A JP2024528540A5 JP 2024528540 A5 JP2024528540 A5 JP 2024528540A5 JP 2023580744 A JP2023580744 A JP 2023580744A JP 2023580744 A JP2023580744 A JP 2023580744A JP 2024528540 A5 JP2024528540 A5 JP 2024528540A5
Authority
JP
Japan
Application number
JP2023580744A
Other languages
Japanese (ja)
Other versions
JPWO2023278449A5 (https=
JP2024528540A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/035320 external-priority patent/WO2023278449A1/en
Publication of JP2024528540A publication Critical patent/JP2024528540A/ja
Publication of JP2024528540A5 publication Critical patent/JP2024528540A5/ja
Publication of JPWO2023278449A5 publication Critical patent/JPWO2023278449A5/ja
Pending legal-status Critical Current

Links

JP2023580744A 2021-06-29 2022-06-28 遺伝子操作されたガイドｒｎａ及びポリヌクレオチド Pending JP2024528540A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163216178P 2021-06-29 2021-06-29
US63/216,178 2021-06-29
US202163277701P 2021-11-10 2021-11-10
US63/277,701 2021-11-10
US202263303680P 2022-01-27 2022-01-27
US63/303,680 2022-01-27
US202263345059P 2022-05-24 2022-05-24
US63/345,059 2022-05-24
PCT/US2022/035320 WO2023278449A1 (en) 2021-06-29 2022-06-28 Engineered guide rnas and polynucleotides

Publications (3)

Publication Number Publication Date
JP2024528540A JP2024528540A (ja) 2024-07-30
JP2024528540A5 true JP2024528540A5 (https=) 2025-08-07
JPWO2023278449A5 JPWO2023278449A5 (https=) 2025-08-07

Family

ID=82701937

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023580744A Pending JP2024528540A (ja) 2021-06-29 2022-06-28 遺伝子操作されたガイドｒｎａ及びポリヌクレオチド

Country Status (6)

Country Link
US (1) US20240271139A1 (https=)
EP (1) EP4363579A1 (https=)
JP (1) JP2024528540A (https=)
AU (1) AU2022301997A1 (https=)
CA (1) CA3223109A1 (https=)
WO (1) WO2023278449A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3236391A1 (en) * 2021-10-26 2023-05-04 Yiannis SAVVA Rna-editing compositions and methods of use
WO2024137993A2 (en) * 2022-12-23 2024-06-27 Shape Therapeutics Inc. Engineered guide rnas and polynucleotides
WO2026006483A1 (en) * 2024-06-25 2026-01-02 Shape Therapeutics Inc. Snca vectors and engineered guide rnas
WO2026006334A1 (en) * 2024-06-25 2026-01-02 Shape Therapeutics Inc. Dux4 vectors and engineered guide rnas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021113270A1 (en) * 2019-12-02 2021-06-10 Shape Therapeutics Inc. Therapeutic editing
CA3177380A1 (en) * 2020-05-26 2021-12-02 Shape Therapeutics Inc. Compositions and methods for modifying target rnas
WO2022103852A1 (en) * 2020-11-11 2022-05-19 Shape Therapeutics Inc. Rna-editing compositions and methods of use
WO2022119975A2 (en) * 2020-12-01 2022-06-09 Shape Therapeutics Inc. High throughput rna-editing screening methods

Similar Documents

Publication Publication Date Title
JP2024528540A5 (https=)
CL2025001979A1 (es) Métodos y composiciones para la transducción de genes y para controlar la actividad de receptores
CL2025003670A1 (es) Calentador con adición remota de aire de combustión.
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307044316S (https=)
BY13164U (https=)
BY13175U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)
BY13176U (https=)